OTCPK:SPLID - Post by User
Post by
geodcanon Oct 18, 2019 1:23pm
190 Views
Post# 30244580
EAT has a lot of shares
EAT has a lot of sharesand fingerprints on a lot of companies. EAT, Calyx, Palo Verde, Pasa Verde, La Pine, Neutrisci, Green Therapeutics, Abba Medix, Sol Daze, Marley Nat and J-Meds too.
EAT also had a lot of stall-outs along the way and some of those deals didn't take. Whether they are forgotten and we moved on is uncertain.
EAT has had a lot of difficulty with developing our own products but did the next best thing and hooked up with Calyx and distribution might be our claim to fortune. Buying good products and retailing them makes sense, especially with our oil capability, which is double bubble if suppliers use our oil. Oil is becoming commoditized along with the grow ops of which there are plenty and subject to serious price competition. I have raised the issue before in regards to "premium" oil and "good enough oil" and the premium stuff might be left in the cold. Material costs always come into play with manufacturing but not so much as a retailer. If people know enough to buy premium and the products are good they will spend crazy amounts of money but adequate products for the unknowing will probably garner the bulk of the segment.
If EAT can pick up some suppiers of infused goods and all other forms and run a retail operation with marked up products, then that is a business plan that works.
I want to see them put full effort into California and Canada phase 2 can sit on the back burner until we solve packaging and advertising pitfalls and create a level field with Big Alcohol who can put nice labels on products and advertise them. Not fixing this will put Canada behind the eight ball.
It is nice to see some upward movement on EAT's sp. It might be an indication of a turn around in the sector. glta and dyodd